Zhang, A., Hu, G., Yin, X., Lu, S., Mo, X., Sun, Y., Wang, Y., Xu, L., Zhang, X., Zhao, X., Huang, X., Cheng, Y., Lv, M. (2025). Selecting the optimal bridging therapy for B-ALL: A multicenter comparison of blinatumomab, inotuzumab ozogamicin, and CAR-T prior to allo-HSCT. Blood. https://doi.org/10.1182/blood-2025-4298